mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-05 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |